Editorial: The role of radiotherapy in reshaping tumor immune microenvironment

Bibliographic Details
Published in:	Frontiers in Immunology
Main Authors:	Xiaoyu Hu, Mengyu Zhao, Jinbo Yue
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-12-01
Subjects:	radiotherapy immunotherapy immune microenvironment autophagy colorectal cancer immunotherapy represented by immune checkpoint inhibitors (ICIs)
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1340844/full

Similar Items

Gut Microbiota Reshapes the Tumor Microenvironment and Affects the Efficacy of Colorectal Cancer Immunotherapy
by: Fayuan Wang, et al.
Published: (2025-06-01)

The role of tumor immune microenvironment in chordoma: promising immunotherapy strategies
by: Jiuhui Xu, et al.
Published: (2023-09-01)

Combining radiation with immune checkpoint inhibitors therapy for HCC: From the alteration of the immune microenvironment by radiotherapy
by: Kaixiao Zhou, et al.
Published: (2022-12-01)

Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors
by: Yuze Wu, et al.
Published: (2024-07-01)

Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer
by: Kassidy M. Jungles, et al.
Published: (2022-10-01)

Editorial: Tertiary lymphoid structures (TLS) in the tumor immune microenvironment
by: Xinbo Gao, et al.
Published: (2025-01-01)

Targeting immune microenvironment in cervical cancer: current research and advances
by: Zhen Zhang, et al.
Published: (2025-08-01)

Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
by: Muhammad Zaeem Noman, et al.
Published: (2019-09-01)

Recent advances in novel tumor immunotherapy strategies based on regulating the tumor microenvironment and immune checkpoints
by: Hanhui Jing, et al.
Published: (2025-06-01)

Editorial: The tumor microenvironment and immunotherapy for head and neck tumors
by: Yifan Jiang, et al.
Published: (2025-06-01)

Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy
by: Yan Yang, et al.
Published: (2025-05-01)

The role of T cells in tumor radiotherapy combined with immunotherapy and gastrointestinal adverse events
by: SHI Xiaolin, et al.
Published: (2021-02-01)

Opportunistic Infections and Immune-Related Adverse Events Associated with Administering Immune Checkpoint Inhibitors: A Narrative Review
by: Ranferi Ocaña-Guzmán, et al.
Published: (2023-08-01)

The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma
by: Jingchang Zhang, et al.
Published: (2022-07-01)

Establishment of immune suppression by cancer cells in the tumor microenvironment
by: Hiroyoshi NISHIKAWA
Published: (2024-02-01)

A brief glimpse of a tangled web in a small world: Tumor microenvironment
by: Iman M. Talaat, et al.
Published: (2022-08-01)

Immune landscape and immunotherapy for penile cancer
by: Yaxiong Tang, et al.
Published: (2022-11-01)

Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights
by: Randolph J. Noelle, et al.
Published: (2023-09-01)

Moderate toxicity with late onset as a good omen: association between toxicity and survival in the checkpoint inhibitor immunotherapy—a single center experience
by: Anna Rudzińska, et al.
Published: (2025-04-01)

Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1
by: Debayan Mukherjee, et al.
Published: (2023-12-01)

Immune microenvironment and immunotherapy for chordoma
by: Yujia Chen, et al.
Published: (2024-06-01)

Opportunities, obstacles and challenges of nano-immunotherapy in melanoma
by: Zexing Shan, et al.
Published: (2025-08-01)

HPV infection and the immune microenvironment in cervical cancer
by: Yibo Li, et al.
Published: (2025-07-01)

Safety and efficacy of immune checkpoint inhibitors in patients with pre-treatment reduced left ventricular function
by: Maor Tzuberi, et al.
Published: (2025-01-01)

Editorial: Immune checkpoint inhibitors in cancer: balancing the benefits with the side effects?
by: Cristiane J. Gomes-Lima, et al.
Published: (2023-09-01)

Integrative analysis revealed that distinct cuprotosis patterns reshaped tumor microenvironment and responses to immunotherapy of colorectal cancer
by: Ximo Xu, et al.
Published: (2023-03-01)

Targeting the immune microenvironment during immunotherapy for solid tumors
by: Aiman Sabaawy, et al.
Published: (2021-09-01)

Effect of stereotactic radiotherapy on immune microenvironment of lung cancer
by: Yao Xiao, et al.
Published: (2022-09-01)

Programmed Cell Death Protein 1 Axis Inhibition in Viral Infections: Clinical Data and Therapeutic Opportunities
by: Konstantinos Tsiakos, et al.
Published: (2022-10-01)

Stereotactic body radiation therapy or conventional fractionated radiotherapy combined with immune checkpoint inhibitors? From biological perspectives
by: Yanmei Liu, et al.
Published: (2025-08-01)

HCC and Immunotherapy: The Potential Predictive Role of Gut Microbiota and Future Therapeutic Strategies
by: Carmelo Laface, et al.
Published: (2025-02-01)

Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma
by: JinSong Li, et al.
Published: (2025-02-01)

Advances in immune microenvironment and immunotherapy strategy for colorectal cancer
by: Yang Changjiang, et al.
Published: (2022-08-01)

Synergizing radiotherapy and immunotherapy: Current challenges and strategies for optimization
by: Greeshma Rajeev-Kumar, et al.
Published: (2023-02-01)

Mechanistic rationales for combining immunotherapy with radiotherapy
by: Alexander Chi, et al.
Published: (2023-06-01)

Unraveling the triad of immunotherapy, tumor microenvironment, and skeletal muscle biomechanics in oncology
by: Shuang Ma, et al.
Published: (2025-04-01)

Editorial: The role of immune checkpoints in gastrointestinal diseases
by: Xiaofei Shen, et al.
Published: (2023-07-01)

Characterization of immune cell populations in syngeneic murine tumor models
by: Sofie Snipstad, et al.
Published: (2023-05-01)

Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME)
by: Anne Catherine Bretz, et al.
Published: (2019-11-01)

Repurposing drugs for solid tumor treatment: focus on immune checkpoint inhibitors
by: Qingxu Liu, et al.
Published: (2023-11-01)